Titan Biotech Limited (BOM:524717)
India · Delayed Price · Currency is INR 383.20
-8.30 (-2.12%)
At close: Oct 5, 2026
Titan Biotech Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 2,189 | 2,062 | 1,565 | 1,641 | 1,440 | 1,235 |
Revenue Growth | 36.93% | 31.79% | -4.64% | 13.94% | 16.55% | -13.14% |
Gross Profit Gross Profit Growth | 1,187 | 1,077 | 822.57 | 871.36 | 729.57 | 637.21 |
Operating Income Operating Income Growth | 372.14 | 335.3 | 211.1 | 308.08 | 268.05 | 288.13 |
Net Income Net Income Growth | 338.79 | 298.85 | 215.32 | 248.53 | 248.44 | 216.84 |
Earnings Per Share EPS Growth | 8.20 | 7.23 | 5.21 | 6.01 | 6.01 | 5.25 |
EPS Growth | 54.00% | 38.77% | -13.37% | 0.02% | 14.57% | -28.52% |
| Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
India India Growth | 1,259 | 1,025 | 1,076 | 997.99 | 959.16 |
Overseas Overseas Growth | 803.32 | 539.03 | 564.94 | 442.01 | 276.33 |
Total Total Growth | 2,062 | 1,565 | 1,641 | 1,440 | 1,235 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 18.73 | 18.73 | 55.58 | 32.86 | 48.64 | 68.14 |
Total Debt Total Debt Growth | 57.07 | 61.03 | 32.27 | 87.48 | 85.12 | 89.3 |
Net Cash (Debt) Net Cash Growth | -38.34 | -42.3 | 23.31 | -54.63 | -36.48 | -21.16 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.93 | -1.02 | 0.56 | -1.32 | -0.88 | -0.51 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | 304.21 | 201.23 | 211.46 | 211.78 | 220.41 |
Capital Expenditures CapEx Growth | - | -74.28 | -85.21 | -194.85 | -127.34 | -63.11 |
Free Cash Flow Free Cash Flow Growth | - | 229.93 | 116.03 | 16.61 | 84.45 | 157.29 |
Free Cash Flow Growth | - | 98.16% | 598.38% | -80.33% | -46.31% | -2.13% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 54.25% | 52.21% | 52.58% | 53.11% | 50.66% | 51.58% |
Operating Margin | 17.00% | 16.26% | 13.49% | 18.78% | 18.62% | 23.32% |
Pretax Margin | 20.99% | 19.70% | 17.66% | 19.94% | 22.18% | 23.45% |
Profit Margin | 15.48% | 14.49% | 13.76% | 15.15% | 17.25% | 17.55% |
FCF Margin | - | 11.15% | 7.42% | 1.01% | 5.86% | 12.73% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.500 | 0.500 | 0.400 | 0.400 | 0.360 | 0.300 |
Dividend Per Share Growth | 25.00% | 25.00% | 0% | 11.11% | 20.00% | 0% |
Dividend Yield | 0.13% | 0.11% | 0.48% | 0.38% | 0.92% | 0.58% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 46.74 | 63.28 | 16.18 | 17.56 | 6.55 | 9.99 |
P/FCF Ratio | 68.86 | 82.25 | 30.02 | 262.72 | 19.26 | 13.77 |
PS Ratio | 7.23 | 9.17 | 2.23 | 2.66 | 1.13 | 1.75 |